Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Hydrogen Peroxide
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : AXA Japan
Deal Size : Undisclosed
Deal Type : Financing
KORTUC Inc. Closes Financing from AXA Japan
Details : KORTUC will use the financing to fund Research and Development activities, accelerate its Pivotal Phase II Study on a Hydrogen Peroxide candidate in the UK and pursue additional Pivotal Studies in the US.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
July 29, 2021
Lead Product(s) : Hydrogen Peroxide
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : AXA Japan
Deal Size : Undisclosed
Deal Type : Financing
LOOKING FOR A SUPPLIER?